A Survey to Evaluate the Cardiovascular Risk Status of Subjects With Pre-Diabetes in Hong Kong (JADE-HK2)

This study is ongoing, but not recruiting participants.
Sponsor:
Information provided by (Responsible Party):
Juliana Chan, Chinese University of Hong Kong
ClinicalTrials.gov Identifier:
NCT00786890
First received: November 5, 2008
Last updated: August 21, 2015
Last verified: August 2015
  Purpose

Hypothesis: A high cardiovascular risk is present in subjects with pre-diabetes in Hong Kong Chinese.

The investigators plan to assess Chinese subjects in Hong Kong who have pre-diabetes (impaired fasting glucose, IFG; or impaired glucose tolerance, IGT) based on oral glucose tolerance test (OGTT) on their cardiovascular risk status such as obesity, hypertension and lipid profile.


Condition Intervention
Prediabetes
Cardiovascular Risk Factors
Other: observational, no intervention needed

Study Type: Observational
Study Design: Observational Model: Case-Only
Time Perspective: Prospective
Official Title: A Survey to Evaluate the Cardiovascular Risk Status of Subjects With Pre-Diabetes in Hong Kong: The Joint Asia Diabetes Evaluation (JADE) Program Sub-study 2 (JADE-HK2)

Resource links provided by NLM:


Further study details as provided by Chinese University of Hong Kong:

Primary Outcome Measures:
  • Cardiovascular risk factors: anthroprometric parameters, blood pressure and lipid profiles [ Time Frame: instant ] [ Designated as safety issue: No ]

Estimated Enrollment: 3000
Study Start Date: November 2008
Estimated Study Completion Date: December 2018
Estimated Primary Completion Date: December 2018 (Final data collection date for primary outcome measure)
Groups/Cohorts Assigned Interventions
no treatment
observational, no treatment needed
Other: observational, no intervention needed
observational, no intervention needed

  Eligibility

Ages Eligible for Study:   18 Years and older
Genders Eligible for Study:   Both
Accepts Healthy Volunteers:   No
Sampling Method:   Non-Probability Sample
Study Population

Hong Kong Chinese with pre-diabetes

Criteria

Inclusion Criteria:

  • Hong Kong Chinese with confirmed IFG or IGT by OGTT

Exclusion Criteria:

  • Confirmed diabetic patients
  Contacts and Locations
Choosing to participate in a study is an important personal decision. Talk with your doctor and family members or friends about deciding to join a study. To learn more about this study, you or your doctor may contact the study research staff using the Contacts provided below. For general information, see Learn About Clinical Studies.

Please refer to this study by its ClinicalTrials.gov identifier: NCT00786890

Locations
China
Hong Kong Institute of Diabetes and Obesity
Hong Kong, China, HK
Sponsors and Collaborators
Chinese University of Hong Kong
  More Information

No publications provided

Responsible Party: Juliana Chan, Professor, Chinese University of Hong Kong
ClinicalTrials.gov Identifier: NCT00786890     History of Changes
Other Study ID Numbers: ADF-2008-2
Study First Received: November 5, 2008
Last Updated: August 21, 2015
Health Authority: Hong Kong: Joint CUHK-NTEC Clinical Research Ethics Committee

Keywords provided by Chinese University of Hong Kong:
Prediabetes (IFG, IGT)
Hong Kong Chinese
Cardiovascular risk factors

Additional relevant MeSH terms:
Glucose Intolerance
Prediabetic State
Diabetes Mellitus
Endocrine System Diseases
Glucose Metabolism Disorders
Hyperglycemia
Metabolic Diseases

ClinicalTrials.gov processed this record on August 27, 2015